JP2012512255A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512255A5
JP2012512255A5 JP2011542411A JP2011542411A JP2012512255A5 JP 2012512255 A5 JP2012512255 A5 JP 2012512255A5 JP 2011542411 A JP2011542411 A JP 2011542411A JP 2011542411 A JP2011542411 A JP 2011542411A JP 2012512255 A5 JP2012512255 A5 JP 2012512255A5
Authority
JP
Japan
Prior art keywords
pyridin
ylamino
phenoxy
phenyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2011542411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012512255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/068330 external-priority patent/WO2010077992A1/en
Publication of JP2012512255A publication Critical patent/JP2012512255A/ja
Publication of JP2012512255A5 publication Critical patent/JP2012512255A5/ja
Ceased legal-status Critical Current

Links

JP2011542411A 2008-12-17 2009-12-16 ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物 Ceased JP2012512255A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13843408P 2008-12-17 2008-12-17
US13844308P 2008-12-17 2008-12-17
US61/138,443 2008-12-17
US61/138,434 2008-12-17
PCT/US2009/068330 WO2010077992A1 (en) 2008-12-17 2009-12-16 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors

Publications (2)

Publication Number Publication Date
JP2012512255A JP2012512255A (ja) 2012-05-31
JP2012512255A5 true JP2012512255A5 (enExample) 2013-02-14

Family

ID=41718257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011542411A Ceased JP2012512255A (ja) 2008-12-17 2009-12-16 ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物

Country Status (10)

Country Link
US (1) US8637500B2 (enExample)
EP (1) EP2376455B1 (enExample)
JP (1) JP2012512255A (enExample)
AR (1) AR074775A1 (enExample)
AU (1) AU2009333214B2 (enExample)
CA (1) CA2746307C (enExample)
ES (1) ES2397934T3 (enExample)
MX (1) MX2011006575A (enExample)
TW (1) TW201035051A (enExample)
WO (1) WO2010077992A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9051296B2 (en) 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
US8470820B2 (en) * 2010-01-22 2013-06-25 Hoffman-La Roche Inc. Nitrogen-containing heteroaryl derivatives
WO2012018909A1 (en) * 2010-08-04 2012-02-09 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds
CA2827724A1 (en) 2011-02-18 2012-08-23 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
WO2012162213A1 (en) * 2011-05-24 2012-11-29 Merck Sharp & Dohme Corp. Aryloxymethyl cyclopropane derivatives as pde10 inhibitors
MX344600B (es) * 2011-06-27 2016-12-20 Janssen Pharmaceutica Nv Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina.
MY157301A (en) * 2011-08-25 2016-05-31 Merck Sharp & Dohme Pyrimidine pde10 inhibitors
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
WO2013148537A1 (en) * 2012-03-29 2013-10-03 Ning Xi Substituted spirobicyclic compounds and methods of use
WO2013171640A1 (en) 2012-05-15 2013-11-21 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
HK1206250A1 (en) 2012-06-26 2016-01-08 Janssen Pharmaceutica Nv Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and ped 10 inhibitors for use in the treatment of neurological or metabolic disorders
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
KR20180052635A (ko) 2015-09-18 2018-05-18 가켄 세이야쿠 가부시키가이샤 바이아릴 유도체 및 이를 포함하는 약제
EA202092442A3 (ru) 2016-06-07 2021-08-31 Джакобио Фармасьютикалс Ко., Лтд. Новые гетероциклические производные, применимые в качестве ингибиторов shp2
CN108779115B (zh) 2016-10-14 2021-02-26 江苏恒瑞医药股份有限公司 五元杂芳环并桥环类衍生物、其制备方法及其在医药上的应用
KR102317480B1 (ko) 2017-03-23 2021-10-25 자코바이오 파마슈티칼스 컴퍼니 리미티드 Shp2 억제제로서 유용한 신규한 헤테로환형 유도체
US11299488B2 (en) * 2017-07-12 2022-04-12 Bristol-Myers Squibb Company Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure
CN108997230B (zh) * 2018-07-26 2020-08-04 山东大学 具有基质金属蛋白酶抑制活性的喹喔啉衍生物及其制备方法和应用
WO2020063760A1 (en) 2018-09-26 2020-04-02 Jacobio Pharmaceuticals Co., Ltd. Novel heterocyclic derivatives useful as shp2 inhibitors
US12359128B2 (en) 2020-12-17 2025-07-15 Merck Patent Gmbh Heteroaromatic isothiocyanates
CN117024405A (zh) * 2022-05-09 2023-11-10 浙江同源康医药股份有限公司 多环类化合物及其用途
WO2025024681A1 (en) * 2023-07-25 2025-01-30 The Regents Of The University Of California Ire1alpha inhibitors and uses thereof
WO2025024688A1 (en) * 2023-07-25 2025-01-30 The Regents Of The University Of California Ire1alpha inhibitors and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
EP1255735A2 (en) * 2000-02-03 2002-11-13 Eli Lilly And Company Pyridine derivatives as potentiators of glutamate receptors
WO2001087845A2 (en) * 2000-05-15 2001-11-22 Fujisawa Pharmaceutical Co., Ltd. N-containing heterocyclic compounds and their use as 5-ht antagonists
EP1635828B1 (en) 2003-04-04 2008-04-23 H. Lundbeck A/S 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
JP2007508241A (ja) 2003-07-31 2007-04-05 バイエル・フアーマシユーチカルズ・コーポレーシヨン Pde10a阻害剤を用いる糖尿病および関連障害の処置方法
CN1845915A (zh) * 2003-09-02 2006-10-11 默克公司 作为亲代谢谷氨酸受体-5的调节剂的联吡啶胺和醚类化合物
AU2005221140A1 (en) * 2004-03-08 2005-09-22 Amgen Inc. Therapeutic modulation of PPAR (gamma) activity
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
NL2000397C2 (nl) * 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
US7560551B2 (en) * 2006-01-23 2009-07-14 Amgen Inc. Aurora kinase modulators and method of use
MY161884A (en) 2006-01-23 2017-05-15 Amgen Inc Aurora kinase modulators and method of use
WO2007129183A2 (en) 2006-05-02 2007-11-15 Pfizer Products Inc. Bicyclic heteroaryl compounds as pde10 inhibitors
US20080090834A1 (en) * 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
US8236823B2 (en) 2006-10-27 2012-08-07 Amgen Inc. Multi-cyclic compounds and methods of use
CA2672440A1 (en) 2006-12-20 2008-07-03 Amgen Inc. Substituted heterocycles and methods of use
WO2009081259A1 (en) 2007-12-21 2009-07-02 Pfizer Inc. Phenoxy-pyridyl derivatives
AU2009271414A1 (en) 2008-06-20 2010-01-21 Metabolex, Inc. Aryl GPR119 agonists and uses thereof
TWI396689B (zh) * 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物

Similar Documents

Publication Publication Date Title
JP2012512255A5 (enExample)
JP7028861B2 (ja) ピリジル置換のインドール化合物
JP6348891B2 (ja) Cxcr4受容体アンタゴニスト
JP5650735B2 (ja) タンパク質キナーゼ調節剤としてのピリジンおよびピラジン誘導体
KR101677778B1 (ko) 아미노피라진 유도체 및 의약
US20110130380A1 (en) Heteroaryl Kinase Inhibitors
US20120157433A1 (en) Heteroaryl Compounds as Kinase Inhibitors
JP2016535003A5 (enExample)
US20120165306A1 (en) Pyrazinylpyridines useful for the treatment of proliferative diseases
JP2013537180A (ja) トリアジン−オキサジアゾール類
US20130303507A1 (en) Substituted hetero-biaryl compounds and their uses
WO2012101064A1 (en) N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
JP2012512255A (ja) ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物
WO2012101063A1 (en) N-acyl pyridine biaryl compounds and their uses
JP2014501269A5 (enExample)
SI2790705T1 (en) Use of activity inhibitors or PI3K function
JP2009544626A (ja) Itpkb阻害剤としての化合物および組成物
JPWO2012020786A1 (ja) 医薬組成物
JP5668756B2 (ja) 悪性リンパ腫治療剤
WO2012005299A1 (ja) Rosチロシンキナーゼ阻害剤
WO2007089031A1 (en) Piperidine derivatives as tachykinin receptor antagonists
AU2010209825A1 (en) Piperidine derivatives as NK3 receptor antagonists
WO2023176972A1 (ja) 高リスク骨髄線維症の治療剤